Research progress on the mechanism of gene action on tetralogy of Fallot (TOF)
New Discovery · 2025
DOI: 10.61958/ndfm3158 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Discovery, 2025. Verfasst von Dong-Yang Zhao.
Abstract (Originalsprache)
Tetralogy of Fallot (TOF) is a complex congenital heart defect whose pathogenesis remains a focus of active research, given its implications for fetal health and parental decision-making. This study aimed to elucidate the underlying mechanisms of TOF and explore strategies for prenatal prevention, screening, and early intervention. A comprehensive literature review was conducted using databases such as PubMed and CNC, retrieving 110 relevant articles based on keywords including "Tetralogy of Fallot," "gene," and "chromosome." The evidence indicates that both genetic and environmental factors contribute to TOF development. Genetic influences include single or multiple gene mutations, epigenetic modifications—particularly DNA methylation—copy number variations (CNVs), and structural or numerical chromosomal abnormalities. Environmental risk factors encompass physical agents (e.g., radiation, electromagnetic exposure), chemical toxins (e.g., drugs, building materials, organic solvents, pesticides, air pollutants), biological infections (e.g., viral or bacterial), and psychosocial stressors such as maternal anxiety. These findings underscore the multifactorial etiology of TOF and highlight the importance of integrated approaches for its early detection and prevention.
Zitieren
APA
Zhao, D. (2025). Research progress on the mechanism of gene action on tetralogy of Fallot (TOF). New Discovery. https://doi.org/10.61958/ndfm3158
Vancouver
Zhao D. Research progress on the mechanism of gene action on tetralogy of Fallot (TOF). New Discovery. 2025. doi:10.61958/ndfm3158
BibTeX
@article{Zhao2025,
author = {Zhao, Dong-Yang},
title = {Research progress on the mechanism of gene action on tetralogy of Fallot (TOF)},
journal = {New Discovery},
year = {2025},
doi = {10.61958/ndfm3158}
}
EUVIMED